Salvatore S

No ORCID on file · 13 papers in corpus · active 2014-2024

Study types

  • article 6
  • review 2
  • meta-analysis 1
  • other 1

Condition tags

  • endometriosis 9
  • bladder_endometriosis 2
  • die_deep_infiltrating 1
article 2024
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590.2024.2432479

OBJECTIVE: To assess the prevalence and the characteristics of pelvic floor dysfunction (PFD) in women with endometriosis. METHODS: This is a methodological paper that describes the 'Endometriosis and Pelvic Floor Dysfunction' (EndoPFD) mu…

2024
Journal of clinical medicine ·doi:10.3390/jcm13051257

This review navigates the intricate relationship between gender, hormonal influences, and the progression of autosomal dominant polycystic kidney disease (ADPKD), highlighting the limited literature on this crucial topic. The study explores…

meta-analysis 2024
Journal of minimally invasive gynecology ·doi:10.1016/j.jmig.2024.09.020

OBJECTIVE: To evaluate the impact of deep infiltrating endometriosis (DIE) on bladder function and the possible impact of surgical resection. DATA SOURCES: A systematic literature research was performed using the PubMed/MEDLINE and EMBASE …

2022
Medicina (Kaunas, Lithuania) ·doi:10.3390/medicina58080981

Female sexual dysfunctions represent a real widespread problem, usually faced from a psychological point of view; however, millions of women worldwide are impacted by pelvic floor dysfunction, personal shame and social taboos, however, cont…

2021
Pathologica
other 2015
Journal of minimally invasive gynecology ·doi:10.1016/j.jmig.2015.02.008
article 2014
Annals of the New York Academy of Sciences ·doi:10.1111/nyas.12411

Endometriosis is an estrogen-dependent inflammatory disease defined by the growth of endometrial stroma and glands outside of the uterus. Epidemiological and clinical studies show that estrogen is essential for the growth of endometriosis. …

article 2014
review 2014
Expert opinion on pharmacotherapy ·doi:10.1517/14656566.2014.943734

INTRODUCTION: Dienogest (DNG) is an oral progestin, derivative of 19-nortestosterone, that has recently been introduced for the treatment of endometriosis. AREAS COVERED: This review examines the clinical efficacy, safety and tolerability o…

article 2014
article 2014
review 2014
Expert opinion on pharmacotherapy ·doi:10.1517/14656566.2014.916279

INTRODUCTION: Over the past 30 years, gonadotropin-releasing hormone agonists (GnRH-a) have been used to induce a hypoestrogenic status in women with endometriosis with the aim to cause an improvement in pain symptoms similar to that observ…

article 2014
International urogynecology journal ·doi:10.1007/s00192-014-2487-6

Bladder endometriosis causes urinary symptoms including frequency, dysuria, cyclic haematuria and non-urinary pain symptoms. To our knowledge, the association of bladder endometriosis with urinary incontinence has not been described. We pre…